Literature DB >> 15554384

Nerve growth factor stimulates MMP-2 expression and activity and increases invasion by human pancreatic cancer cells.

Yuji Okada1, Guido Eibl, Sushovan Guha, John P Duffy, Howard A Reber, Oscar J Hines.   

Abstract

Pancreatic cancer frequently invades and migrates along neural tissue. Although the exact mechanisms are unknown, perineural invasion negatively impacts prognosis for pancreatic cancer patients. Matrix metalloproteinases (MMPs) are overexpressed in pancreatic cancer and are associated with poor prognosis. We hypothesized that nerve growth factor (NGF) released from neural tissue increases the invasive properties of pancreatic cancer cells. In the present study we investigated the effect of NGF on the expression and activity of MMP-2 in human pancreatic cancer cells. NGF dose dependently increased MMP-2 protein in the culture medium and stimulated MMP-2 gelatinolytic activity. This effect was mediated by specific binding of NGF to its receptor trk A, which was detected on all pancreatic cancer cells, with subsequent activation of the p44/42 MAPK signaling pathway. The NGF-induced increase in MMP-2 expression and activity lead to an enhanced invasion in vitro. These findings support the hypothesis that neurotrophic factors, e.g., NGF, are critically involved in mediating perineural invasion of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15554384     DOI: 10.1023/b:clin.0000046131.24625.54

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  25 in total

1.  Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior.

Authors:  S J Miknyoczki; D Lang; L Huang; A J Klein-Szanto; C A Dionne; B A Ruggeri
Journal:  Int J Cancer       Date:  1999-05-05       Impact factor: 7.396

2.  Perineural invasion in pancreatic cancer.

Authors:  Ichiro Hirai; Wataru Kimura; Koichiro Ozawa; Shun Kudo; Koichi Suto; Hiroshi Kuzu; Akira Fuse
Journal:  Pancreas       Date:  2002-01       Impact factor: 3.327

3.  Involvement of matrix metalloproteinase-2 activity in invasion and metastasis of pancreatic carcinoma.

Authors:  T Koshiba; R Hosotani; M Wada; Y Miyamoto; K Fujimoto; J U Lee; R Doi; S Arii; M Imamura
Journal:  Cancer       Date:  1998-02-15       Impact factor: 6.860

4.  Cancer statistics, 2002.

Authors:  Ahmedin Jemal; Andrea Thomas; Taylor Murray; Michael Thun
Journal:  CA Cancer J Clin       Date:  2002 Jan-Feb       Impact factor: 508.702

5.  Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.

Authors:  H Yamamoto; F Itoh; S Iku; Y Adachi; H Fukushima; S Sasaki; M Mukaiya; K Hirata; K Imai
Journal:  J Clin Oncol       Date:  2001-02-15       Impact factor: 44.544

6.  Expression of matrix metalloproteinases and the tissue inhibitors of metalloproteinases and their local invasiveness and metastasis in Chinese human pancreatic cancer.

Authors:  Y L Gong; G M Xu; W D Huang; L B Chen
Journal:  J Surg Oncol       Date:  2000-02       Impact factor: 3.454

7.  Neurotrophic factors in prostate and prostatic cancer.

Authors:  A A Geldof; E P Van Haarst; D W W Newling
Journal:  Prostate Cancer Prostatic Dis       Date:  1998-09       Impact factor: 5.554

8.  Expression of nerve growth factor in human pancreatic beta cells.

Authors:  Román Vidaltamayo; Carlos M Mery; Arturo Angeles-Angeles; Guillermo Robles-Díaz; Marcia Hiriart
Journal:  Growth Factors       Date:  2003 Sep-Dec       Impact factor: 2.511

9.  Reverse transcription-PCR analysis of laser-captured cells points to potential paracrine and autocrine actions of neurotrophins in pancreatic cancer.

Authors:  Knut Ketterer; Shyam Rao; Helmut Friess; John Weiss; Markus W Büchler; Murray Korc
Journal:  Clin Cancer Res       Date:  2003-11-01       Impact factor: 12.531

10.  Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer.

Authors:  T M Gress; F Müller-Pillasch; M M Lerch; H Friess; M Büchler; G Adler
Journal:  Int J Cancer       Date:  1995-08-09       Impact factor: 7.396

View more
  35 in total

Review 1.  Perineural invasion and associated pain in pancreatic cancer.

Authors:  Aditi A Bapat; Galen Hostetter; Daniel D Von Hoff; Haiyong Han
Journal:  Nat Rev Cancer       Date:  2011-09-23       Impact factor: 60.716

Review 2.  Prognostic value of perineural invasion in colorectal cancer: a meta-analysis.

Authors:  Yuchong Yang; Xuanzhang Huang; Jingxu Sun; Peng Gao; Yongxi Song; Xiaowan Chen; Junhua Zhao; Zhenning Wang
Journal:  J Gastrointest Surg       Date:  2015-02-07       Impact factor: 3.452

Review 3.  Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.

Authors:  Xuqi Li; Qingyong Ma; Qinhong Xu; Wanxing Duan; Jianjun Lei; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

Review 4.  Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancer.

Authors:  Han Liu; Qingyong Ma; Qinhong Xu; Jianjun Lei; Xuqi Li; Zheng Wang; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  Diagnostic value of neurotrophin expression in malignant pleural effusions.

Authors:  Bernard C Duysinx; Astrid Paulus; Vincent Heinen; Delphine Nguyen; Monique Henket; Jean-Louis Corhay; Renaud Louis
Journal:  Exp Ther Med       Date:  2011-06-30       Impact factor: 2.447

Review 6.  A starring role for stellate cells in the pancreatic cancer microenvironment.

Authors:  Minoti V Apte; Jeremy S Wilson; Aurelia Lugea; Stephen J Pandol
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

7.  Systemic Depletion of Nerve Growth Factor Inhibits Disease Progression in a Genetically Engineered Model of Pancreatic Ductal Adenocarcinoma.

Authors:  Jami L Saloman; Aatur D Singhi; Douglas J Hartman; Daniel P Normolle; Kathryn M Albers; Brian M Davis
Journal:  Pancreas       Date:  2018-08       Impact factor: 3.327

Review 8.  Mechanisms of Perineural Invasion.

Authors:  Richard L Bakst; Richard J Wong
Journal:  J Neurol Surg B Skull Base       Date:  2016-03-10

9.  Mononuclear cell-derived interleukin-1 beta confers chemoresistance in pancreatic cancer cells by upregulation of cyclooxygenase-2.

Authors:  Eliane Angst; Howard A Reber; Oscar J Hines; Guido Eibl
Journal:  Surgery       Date:  2008-06-05       Impact factor: 3.982

10.  Perineural invasion is an independent predictor of outcome in colorectal cancer.

Authors:  Catherine Liebig; Gustavo Ayala; Jonathan Wilks; Gordana Verstovsek; Hao Liu; Neeti Agarwal; David H Berger; Daniel Albo
Journal:  J Clin Oncol       Date:  2009-09-08       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.